Alcon Inc. Swiss: Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.
Vivity X-WAVE technology delivers extended range of vision while maintaining a monofocal-like visual disturbance profile 1,2
PC-IOL option for cataract patients who may not be a candidate for a diffractive IOL
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has commercially launched the first and only non-diffractive extended depth of focus intraocular lens (IOL) in the U.S. the AcrySof IQ Vivity
TM IOL (Vivity). This new presbyopia-mitigating lens is now available to all U.S. ophthalmologists for patients undergoing cataract surgery. Cataracts are the most common cause of vision loss globally.
Alcon Inc. Investors: Alcon Announces Launch of AcrySof IQ Vivity, the First and Only Non-Diffractive Extended Depth of Focus Intraocular Lens in the U.S.
Vivity X-WAVE technology delivers extended range of vision while maintaining a monofocal-like visual disturbance profile 1,2
PC-IOL option for cataract patients who may not be a candidate for a diffractive IOL
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has commercially launched the first and only non-diffractive extended depth of focus intraocular lens (IOL) in the U.S. the AcrySof IQ Vivity
TM IOL (Vivity). This new presbyopia-mitigating lens is now available to all U.S. ophthalmologists for patients undergoing cataract surgery. Cataracts are the most common cause of vision loss globally.
Boozman, Colleagues Introduce Legislation to Stop Medicare Physician Payment Cuts
U.S. Senators John Boozman (R-AR), Cindy Hyde-Smith (R-MS), Kevin Cramer (R-ND), Tom Cotton (R-AR) and Susan Collins (R-ME) introduced legislation to prevent the Centers for Medicare and Medicaid Services’ (CMS) planned physician payment cuts scheduled to begin January 1, 2021.
The
Holding Providers Harmless from Medicare Cuts During COVID-19 Act of 2020 would ensure payments to medical physicians are maintained at current levels for the next two years.
“Cutting physician payments is the last thing CMS should be doing when we’re in the middle of a pandemic. Patients deserve access to quality and affordable health care. This legislation is necessary to achieve this,”
Congress passes Competitive Health Insurance Reform Act
e-mailPrintShare ADA-supported bill repeals McCarran-Ferguson antitrust exemption for health insurance companies December 22, 2020 By Jennifer Garvin
Washington The Senate on Dec. 22 voted to repeal the McCarran-Ferguson antitrust exemption for health insurance companies by passing HR 1418, the Competitive Health Insurance Reform Act.
The House passed the bill on Sept. 21. At press time, President Donald J. Trump was expected to sign the bill into law.
The ADA has been a “longtime advocate of this bill that would reform the McCarran-Ferguson Act of 1945 to ensure that health insurance companies are subject to the same federal antitrust laws that nearly all other industries must comply with in the U.S.,” the Association wrote in an email to dental leaders.
Resize icon
MarketWatch has highlighted these products and services because we think readers will find them useful. This content is independent of the MarketWatch newsroom and we may receive a commission if you buy products through links in this article.
What You Need to Know: Cataracts are a cloudy area in the lens of your eyes that cause blurry vision, faded colors, sensitivity to light, and double vision More than half of all Americans age 80 or older have cataracts or have had surgery to rectify the condition Without insurance, cataract surgery typically costs between $3,783 and $6,898 Original Medicare doesn’t usually include vision coverage, but it does cover cataract surgery